TE_1270
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 317.84 |
| Counts of samples | TCGA_tumor:281; TCGA_normal:0; GTEx:0 |
| TSS | chr1(-):164459589 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_1270.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):164427646,164427666,164428757,164428903,164449657,164449734,164459548,164459590 |
| teRNA_1270.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):164449714,164449734,164459194,164459590 |
| teRNA_1270.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):164427646,164427666,164449657,164449734,164459194,164459590 |
| teRNA_1270.4 | - | Intergenic | Non-coding | Non-coding | chr1(-):164447938,164447958,164449657,164449734,164459194,164459590 |
| teRNA_1270.5 | - | Intergenic | Non-coding | Non-coding | chr1(-):164430776,164430796,164449657,164449734,164459194,164459590 |
| teRNA_1270.6 | - | Intergenic | Non-coding | Non-coding | chr1(-):164428883,164428903,164449657,164449734,164459194,164459590 |
| teRNA_1270.7 | - | Intergenic | Other | MPRPASARARCAHTLTCAHCLALPSEMNPVPQMEMQKSPVFCLAQAGSCRLELFLFGHLGSSLPKCMSVNFLRPSSEADAGTMLHVQPAAELTRSLRVRSWSPSNPLAPKPCTLQLYFSRLFMRGGWMTTGFQRNYFVLSSEEDKVDLNKCPAFNFPEEDLTQESFLPVEGTRQKG* | chr1(-):164427646,164427666,164428757,164428903,164430645,164430796,164449657,164449734,164459194,164459590 |
| teRNA_1270.8 | - | Intergenic | Non-coding | Non-coding | chr1(-):164427330,164427350,164449657,164449734,164459194,164459590 |
| teRNA_1270.9 | - | Intergenic | Non-coding | Non-coding | chr1(-):164384315,164384335,164449657,164449734,164459194,164459590 |
| teRNA_1270.10 | - | Intergenic | Non-coding | Non-coding | chr1(-):164431677,164431697,164449657,164449734,164459194,164459590 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
